Webinar replay

Inova acquires IN-PART: Q&A with leadership

Inova has acquired IN-PART, a digital matchmaking platform that connects the two worlds of university research and industry R&D.

IN-PART's matchmaking platform, Connect, is used by 250+ universities and research institutes to find new partners for commercialization in over 6,000 companies. Their innovation scouting platform, Discover, is used by industry leaders to engage academics, TTOs, and research service departments in over 1,500 institutes with specific R&D challenges or requirements.

Learn from Inova and IN-PART’s leadership teams how this strategic acquisition will answer the difficulties encountered by the life science industry in identifying and connecting with nascent innovation in academic institutions.

Watch this replay to meet Inova and IN-PART’s leadership teams and Q&A:
Caroline Edlund Toulemonde
Caroline Edlund Toulemonde
Chief Strategy Officer
Inova
patrick-speedie
Patrick Speedie
Co-Founder & Co-CEO
IN-PART
robin-knight
Robin Knight
Co-Founder & Director
IN-PART

Resources you may be interested in

Inova-In-Part Acquisition

Inova acquires leading European biotech news media company, Labiotech

Read this post
Inova acquires Labiotech-replay-email

Inova acquires Labiotech: Q&A with leadership

Watch webinar replay
2021s-biggest-deals-partnerships-Thumbnail

Biopharma’s Year in Review: 2021’s biggest deals & partnerships

Read this post

About Inova

Inova accelerates partnering for the future of medicine. Our cloud-based solutions help life science companies manage their biopharma opportunities more efficiently. They find all their partnering information in one place, track their deals and alliances easily and report on their pipeline and activities in seconds.
We have also developed strategic partnerships that make data from the 20 biggest biopharma events automatically available in Inova, providing our users with always up-to-date company and contact information. Over 150 life science companies, including 50% of the top 50 pharmaceutical companies and many midsize pharma and innovative biotechs already use Inova.